Company Filing History:
Years Active: 1993-1995
Title: Innovations by Susan A. Beck in Cancer Research
Introduction
Susan A. Beck is a notable inventor based in Willenhall, GB, recognized for her contributions to cancer research. She has been awarded 3 patents that focus on innovative treatments and diagnostic applications related to cachexia and cancer.
Latest Patents
One of her latest patents involves the use of eicosapentaenoic acid (EPA) to treat cachexia. This patent discloses the formulation of medical preparations that inhibit lipolytic activity and reduce abnormal cAMP levels in adipose tissue cells. Another significant patent describes a biologically active lipolytic factor with a molecular weight substantially less than 5000 daltons, which can be isolated from cachexia-inducing tumors. This factor has potential applications in cancer diagnostics and the identification of anti-cachetic therapeutic agents.
Career Highlights
Susan A. Beck is currently associated with Cancer Research Campaign Technology Limited, where she continues to advance her research in cancer treatment and diagnostics. Her work has significantly contributed to the understanding of cachexia and its implications in cancer patients.
Conclusion
Susan A. Beck's innovative patents and research efforts are paving the way for new treatments and diagnostic tools in the fight against cancer. Her contributions are vital in enhancing the quality of life for patients suffering from cachexia.